Sharon Marsh

8.7k total citations · 1 hit paper
109 papers, 6.7k citations indexed

About

Sharon Marsh is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Sharon Marsh has authored 109 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 51 papers in Oncology and 34 papers in Pharmacology. Recurrent topics in Sharon Marsh's work include Pharmacogenetics and Drug Metabolism (34 papers), Drug Transport and Resistance Mechanisms (20 papers) and Cancer therapeutics and mechanisms (18 papers). Sharon Marsh is often cited by papers focused on Pharmacogenetics and Drug Metabolism (34 papers), Drug Transport and Resistance Mechanisms (20 papers) and Cancer therapeutics and mechanisms (18 papers). Sharon Marsh collaborates with scholars based in United States, Canada and United Kingdom. Sharon Marsh's co-authors include Howard L. McLeod, Teri E. Klein, Russ B. Altman, Caroline F. Thorn, Connie Oshiro, Tina Hernandez‐Boussard, Cristi R. King, Alex Sparreboom, Jaap Verweij and Ron H.J. Mathijssen and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Sharon Marsh

108 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Doxorubicin pathways

2010 1.3k citations Caroline F. Thorn, Connie Oshiro et al. Pharmacogenetics and Genomics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon Marsh United States	43	3.0k	2.9k	1.1k	708	648	109	6.7k
Matthew M. Ames United States	51	2.7k 0.9×	4.0k 1.4×	1.3k 1.2×	1.1k 1.5×	923 1.4×	239	9.3k
Timothy W. Synold United States	39	2.3k 0.8×	2.4k 0.8×	582 0.5×	509 0.7×	651 1.0×	194	5.9k
Alan V. Boddy United Kingdom	41	2.2k 0.7×	2.4k 0.8×	620 0.6×	465 0.7×	670 1.0×	188	5.9k
Jerry M. Collins United States	52	3.1k 1.0×	2.7k 0.9×	989 0.9×	886 1.3×	1.3k 2.0×	176	9.0k
Giuseppe Toffoli Italy	46	3.1k 1.0×	3.9k 1.3×	534 0.5×	1.1k 1.6×	922 1.4×	337	8.8k
Federico Innocenti United States	45	4.9k 1.6×	3.3k 1.1×	1.1k 1.0×	1.2k 1.7×	1.5k 2.3×	211	7.8k
Sharyn D. Baker United States	61	5.3k 1.7×	4.3k 1.4×	1.1k 1.0×	845 1.2×	2.1k 3.3×	240	10.5k
Kees Nooter Netherlands	52	5.4k 1.8×	3.9k 1.3×	563 0.5×	535 0.8×	699 1.1×	149	9.1k
Branimir I. Šikić United States	57	4.9k 1.6×	4.7k 1.6×	402 0.4×	985 1.4×	924 1.4×	225	9.6k
Étienne Chatelut France	43	2.6k 0.9×	1.8k 0.6×	499 0.4×	389 0.5×	1.0k 1.6×	234	6.6k

Countries citing papers authored by Sharon Marsh

Since Specialization

Citations

This map shows the geographic impact of Sharon Marsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Marsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Marsh more than expected).

Fields of papers citing papers by Sharon Marsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Marsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Marsh. The network helps show where Sharon Marsh may publish in the future.

Co-authorship network of co-authors of Sharon Marsh

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Marsh. A scholar is included among the top collaborators of Sharon Marsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Marsh. Sharon Marsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cuffe, Sinéad, Abul Kalam Azad, Xin Qiu, et al.. (2016). ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patients. Cancer Epidemiology. 41. 50–56. 7 indexed citations

Marsh, Sharon, et al.. (2015). AntiC. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 148(3). 118–124. 5 indexed citations

Eng, Lawson, Abul Kalam Azad, Xin Qiu, et al.. (2015). Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome. Carcinogenesis. 36(9). 956–962. 7 indexed citations

Roederer, Mary W, et al.. (2015). Fast And Frugal Trees: Translating Population-Based Pharmacogenomics to Medication Prioritization. Personalized Medicine. 12(2). 117–128. 5 indexed citations

Faluyi, Olusola Olusesan, Lawson Eng, Dangxiao Cheng, et al.. (2013). MicroRNA polymorphisms and esophageal cancer outcome.. Journal of Clinical Oncology. 31(4_suppl). 32–32. 2 indexed citations

Marsh, Sharon, et al.. (2011). Improving Oncology Outcomes Through Targeted Therapeutics Will Require Electronic Delivery Systems. Future Oncology. 7(5). 649–656. 5 indexed citations

Díaz-Padilla, Iván, Eitan Amir, Sharon Marsh, Geoffrey Liu, & Helen Mackay. (2011). Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: A systematic review. Gynecologic Oncology. 124(2). 354–365. 24 indexed citations

Thorn, Caroline F., Connie Oshiro, Sharon Marsh, et al.. (2010). Doxorubicin pathways. Pharmacogenetics and Genomics. 21(7). 440–446. 1292 indexed citations breakdown →

Marsh, Sharon, Howard L. McLeod, M. Eileen Dolan, et al.. (2009). Platinum pathway. Pharmacogenetics and Genomics. 19(7). 563–564. 37 indexed citations

10.

Hoskins, Janelle M., Eugenio Marcuello, Albert Altés, et al.. (2008). Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes. Clinical Cancer Research. 14(6). 1788–1796. 58 indexed citations

11.

Ranganathan, Prabha, Robert Culverhouse, Sharon Marsh, et al.. (2008). Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.. PubMed. 35(4). 572–9. 126 indexed citations

12.

Johnatty, Sharon E., Jonathan Beesley, James Paul, et al.. (2008). ABCB1 ( MDR 1 ) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy. Clinical Cancer Research. 14(17). 5594–5601. 73 indexed citations

13.

Marsh, Sharon. (2008). Cancer Pharmacogenetics. Methods in molecular biology. 448. 437–446. 3 indexed citations

14.

Kroetz, Deanna L., H. L. McLeod, Lena E. Friberg, et al.. (2006). Irinotecan-induced Diarrhea: Functional Significance of the Polymorphic ABCC2 Transporter Protein. Clinical Pharmacology & Therapeutics. 81(1). 42–49. 131 indexed citations

15.

Henningsson, Anja, Sharon Marsh, Walter J. Loos, et al.. (2005). Association ofCYP2C8, CYP3A4, CYP3A5, andABCB1Polymorphisms with the Pharmacokinetics of Paclitaxel. Clinical Cancer Research. 11(22). 8097–8104. 151 indexed citations

16.

Freimuth, Robert R., Ming Xiao, Sharon Marsh, et al.. (2005). Polymorphism discovery in 51 chemotherapy pathway genes. Human Molecular Genetics. 14(23). 3595–3603. 17 indexed citations

17.

Marsh, Sharon & Howard L. McLeod. (2004). Cancer pharmacogenetics. British Journal of Cancer. 90(1). 8–11. 81 indexed citations

18.

Jong, Floris A. de, Sharon Marsh, Ron H.J. Mathijssen, et al.. (2004). ABCG2 Pharmacogenetics. Clinical Cancer Research. 10(17). 5889–5894. 174 indexed citations

19.

Mathijssen, Ron H.J., Sharon Marsh, Mats O. Karlsson, et al.. (2003). Irinotecan pathway genotype analysis to predict pharmacokinetics.. PubMed. 9(9). 3246–53. 209 indexed citations

20.

Marsh, Sharon, C. Zammit, RC Coope, et al.. (1999). Increased expression of fibroblast growth factor 8 in human breast cancer. Oncogene. 18(4). 1053–1060. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact